Tempus AI, Nancy Pelosi's latest stock bet, crashed by 27% in a week — but its long-term prospects could still be intact.

A remarkable start to the year, marked by a 160% surge, has had investors paying close attention to healthcare tech company ...

The acquisition of Ambry Genetics strengthens Tempus AI's genomics capabilities by adding a West Coast lab and expanding ...

Completing its initial public offering on June 14, Tempus AI stock closed at $40.25, and while it rose above this mark from time to time in the second half of 2024, the stock ended the year on a sour ...

Cathie Wood doubled down on Tempus AI, despite the fact that TEM stock erased most of the gains made in the past month.

CompanyOverview|NASDAQ:TEM] Tempus AI (NASDAQ: TEM) is an emerging AI player in the healthcare field with a robust outlook ...

Tempus AI's Q4 financials were slightly below expectations but aligned with preliminary results. See why I remain bullish on ...

Tempus AI stock fell late Monday after the medical artificial intelligence company reported fourth-quarter results.

We recently published a list of 10 AI Stocks on Analysts’ Radar As AI Spending Grows. In this article, we are going to take a ...

Tempus posted a fourth-quarter adjusted net loss of $0.18 per share, $0.02 more per share than estimates by analysts surveyed by Visible Alpha. Revenue jumped 36% year-over-year to $200.7 million, but ...

Despite optimistic news from the CEO yesterday afternoon, the company's shares fell overnight and a major investment house ...

The shift follows the DeepSeek breakthrough that showed it’s possible to reduce the amount of resources needed to run large ...